drug development

Jsuru Therapeutix, Inc. is a biotechnology and drug development startup company that is 100% black and woman owned. It is dedicated to developing targeted therapies and diagnostic tools for multi-therapy resistant cancers, with particular focus on pancreatic cancer. The company aims to engineer and advance cutting-edge therapies for hard-to-treat cancers and transform the standard of care.

biotechnology researchcombination therapy compound developmentin vitro and mice studies

Jurata is committed to simplifying the supply chain for biologics, vaccines, and advanced therapeutics. The company creates thermostable formulations that reduce or eliminate the need for cold chain or other special handling requirements. Its technology, available in film, liquid or vialed form, simplifies manufacturing, streamlines delivery, and enables flexible administration through multiple routes without compromising efficacy. Jurata's team combines a background in drug development, formulation, and manufacturing with experience across a broad range

drug formulationmanufacturingthermostable formulation technology

Kaléo is a global leader in drug-device combinations and auto-injector innovation. The company performs both drug and device development, pairing custom-designed drug-delivery devices with medical breakthroughs of pharmaceutical and government agency partners. Its Aerio Auto-Injector Platform uses Human Factors Engineering, ~155 issued or pending patents, and fully automated manufacturing. Kaléo also offers medical countermeasures for nerve agent exposure and chemical threats, and a portfolio of marketed auto-injector medicines.

auto-injector innovationcontract manufacturingdevice developmentdrug-device combination developmentfully automated manufacturinghuman factors engineeringSupply Chain Management

Kannalife Sciences, Inc., a subsidiary of Neuropathix, Inc., is a biopharmaceutical company focused on discovering, developing and commercializing breakthrough therapeutics targeting neuroinflammation, healthspan and neuropathic pain. Since 2010 it has been involved in research and development of synthetic cannabidiol (CBD) inspired therapeutics through pre-clinical drug discovery. Its lead candidate is KLS-13019, and it conducts R&D at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.

medicinal chemistrypre-clinical drug discoveryresearch and development

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel cancer therapies. Its core technology leverages inhibition of nuclear export (XPO1 inhibition) and it describes itself as the industry leader in oral Selective Inhibitor of Nuclear Export (SINE) technology.

commercializationdrug discoverySINE technologyXPO1 inhibition

Kissaki Biosciences is using novel approaches to advance new oral peptide-based therapeutics, focusing on high value, validated targets in immunology and inflammation (I&I), with particular interest in gastrointestinal disorders such as inflammatory bowel disease (IBD). The team leverages decades of peptide engineering and drug development expertise to accelerate treatments into and through the clinic.

AI modelingbio-panningconstrained macrocycle designpeptide engineeringstructural biology

of page OUR SERVICESFUNDRAISING AND INVESTMENT Provide seed funding Angel investing Investment Due Diligence Institutional investment assistance BUSINESS PLAN DEVELOPMENT Virtual management team Develop business plan Strategic planning Project management Product licensing and Due Diligence Advice and expertise to help improve business performance DRUG COMMERCIALIZATION Specific guidance in terms of operations, supply chain, profitability, management, structure and strategy Expertise to analyze customer insights, brand performance, market trends and competitive response to inform overall strategic plan Financial aptitude to manage spend and coordination of investments across functions Knowledge to ensure compliance with relevant laws, regulations and standards of business conduct and ethics DRUG DEVELOPMENT Oversight of Due Diligence on in-licensing opportunities Research and development.

business plan developmentclinical trial managementDrug commercializationexpert testimonyFundraising and investmentLitigation support servicesMediation and arbitrationmedical writingRegulatory and clinical services

Kura Oncology, Inc. is a biopharmaceutical company that discovers and develops novel cancer therapeutics, aiming to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Its therapies are designed to selectively target cancer cells, and it investigates them in combination with standards of care. It focuses on areas including head and neck cancer, lung cancer and acute leukemias.

clinical developmentdrug discoveryprecision oncology

Kuria Therapeutics is a pharmaceutical company developing a platform of novel NRF2 activators to treat blinding ophthalmic diseases. Its lead candidate, KTX-1161, is a preservative-free topical ophthalmic formulation of SCO-116, a small-molecule NRF2 activator, being advanced through IND-enabling development for Fuchs' endothelial corneal dystrophy.

clinical developmentIND-enabling development